April 21, 2026
According to market projections, the oncology drugs sector is expected to grow from USD 204.39 billion in 2024 to USD 360.79 billion by 2034, reflecting a CAGR of 6.29%. The oncology drugs market is growing due to the increasing incidence of cancer, ...
April 21, 2026
According to market projections, the U.S. oncology drugs sector is expected to grow from USD 95.69 billion in 2024 to USD 246.85 billion by 2034, reflecting a CAGR of 9.94%. The extensive research, scientific innovations, and the market penetration...
April 21, 2026
According to market projections, the immuno-oncology drugs sector is expected to grow from USD 94 billion in 2024 to USD 421.27 billion by 2034, reflecting a CAGR of 16.34%. Across the globe, a rising number of cancer patients is associated with the ...
April 21, 2026
According to market projections, the global biopharmaceutical contract manufacturing market, valued at USD 40.14 billion in 2024, is anticipated to reach USD 115.65 billion by 2034, growing at a CAGR of 11.14% over the next decade.The biopharmaceut...
April 21, 2026
The advanced liver cancer treatment drugs market is expanding due to increased adoption of systemic therapies over traditional chemotherapy and growing approvals of immuno-oncology agents. North America led the market due to the presence of a well-de...
April 14, 2026
Brain Tumor Drugs Market (By Therapy: Targeted Therapy, Chemotherapy, Immunotherapy, Others; By Indication: Pituitary, Meningioma, Glioma, Others; By Distribution Channel: Hospital Pharmacy, Retail & Online Pharmacy, By Region: North America, Asi...
April 21, 2026
According to market projections, the global oncology API market, valued at USD 41.79 billion in 2024, is anticipated to reach USD 69.55 billion by 2034, growing at a CAGR of 5.24% over the next decade. The rising prevalence of cancer and the growing ...
April 16, 2026
Orphan Oncology Market (By Therapy Type: Monoclonal Antibodies, Targeted Therapy, Immunotherapy, Chemotherapy, Cancer Vaccines; By Application: Oncology Treatment, Healthcare, Pharmaceuticals, Research, Clinical Trials; By Drug Modality: Biologi...
April 21, 2026
The global Pre-Dx oncology market is growing with rising cancer incidence and advanced early detection technologies. North America led with 45% share in 2024, while Asia Pacific is fastest-growing. Liquid biopsy tests accounted for 40% revenue, MCED ...
April 21, 2026
According to market projections, the radiation oncology sector is expected to grow from USD 12.45 billion in 2025 to USD 36.78 billion by 2035, reflecting a CAGR of 11.44%. The rising prevalence of cancer and technological advancements drive the glob...
April 21, 2026
Market insights predict the APAC clinical trials industry will increase from USD 18.87 billion in 2025 to USD 41.33 billion by 2035, achieving a CAGR of 7.16%. The market is growing due to the increasing demand for new and effective therapies and ris...
April 21, 2026
Projections indicate that, GMP peptides industry is projected to rise from USD 1.3 billion in 2024 to USD 2.9 billion by 2034, reflecting a CAGR of 8.35% over the next decade. The growing demand for peptide drugs and technological advancements drives...
February 19, 2026
According to market projections, the Europe pharmaceutical market, valued at USD 467.59 billion in 2024, is anticipated to reach USD 820.05 billion by 2034, growing at a CAGR of 5.78% over the next decade. The Europe pharmaceutical market is expandin...
April 21, 2026
Based on market forecasts, the U.S. oncology sector will expand from USD 72.79 billion in 2024 to USD 211.78 billion by 2034, experiencing a CAGR of 11.75%. The West region led the market due to the vital contribution of California in the oncology ...
April 10, 2026
Personalized Cancer Vaccine Market (By Vaccine Type: Neoantigen-Based Vaccines, Dendritic Cell Vaccines, Tumor Cell Vaccines, Viral Vector-Based Vaccines; By Cancer Type: Melanoma, Lung Cancer, Breast Cancer, Prostate Cancer, Colorectal Cancer, Other...
April 24, 2026
Brain Cancer Market (By Product/Solution Type: Therapeutic Treatments, Diagnostic Imaging, Surgical Devices, Supportive Care Products; By Treatment Modality: Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery, Tumor Treating Fi...
April 21, 2026
According to market projections, the oncology drug discovery sector is growing due to the rising prevalence of cancer and increasing demand for targeted, personalized therapies. Advances in genomics and biotechnology are accelerating the development ...
April 02, 2026
AI In Oncology Market ( By Component: Software Solutions, Hardware, Services; By Application: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer Brain Tumors, Others; By End-User: Hospitals, Pharmaceutical Companies, Research Institutes, ...
January 06, 2026
Based on market forecasts, the bRo5 molecules market is witnessing rapid expansion due to increasing pharmaceutical R&D investments, growing adoption of AI-assisted drug discovery platforms, and rising oncology and CNS disorder prevalence. The ma...
April 21, 2026
Forecasts suggest that the non-oncology precision medicine market will expand from USD 83.87 billion in 2024 to USD 193.16 billion by 2034, with a CAGR of 8.7% during this period. Non-Oncology Precision Medicine tailors treatments to individual patie...
February 25, 2026
The United States AI in Oncology market was valued at USD 720.04 million in 2025 and is projected to grow from USD 921.29 million in 2026 to USD 8,467.58 million by 2035, expanding at a strong CAGR of 27.95% during 2026–2035...
April 21, 2026
The veterinary oncology market reached USD 1.58 billion in 2024 and is set to grow to USD 1.77 billion in 2025, reaching USD 4.86 billion by 2034 at a CAGR of 12.14%. The report covers market segmentation by animal, therapy, and cancer type, regional...
January 16, 2026
Market insights predict, the targeted therapy industry is expected to grow from USD 85.69 billion in 2025 to USD 166.53 billion by 2035, driven by a CAGR of 6.87%. In 2024, North America led the targeted therapy market (32%), with Asia Pacific set fo...
April 21, 2026
Based on market forecasts, the U.S. oncology molecular diagnostics sector will expand from USD 810 million in 2024 to USD 2570.17 million by 2034, experiencing a CAGR of 12.24%. In 2024, breast cancer dominated the market, while liver cancer is expec...
April 21, 2026
Market insights predict, the oncology automation industry is expected to grow from USD 2.82 billion in 2024 to USD 7.77 billion by 2034, driven by a CAGR of 10.68%. The oncology automation market is growing due to rising cases of cancer, leading to a...
January 19, 2026
According to market projections, the oncology NGS sector is expected to grow from USD 589.01 million in 2025 to USD 2538.52 million by 2035, reflecting a CAGR of 15.73%. The demand for NGS in oncology is high due to growing cases of cancer and R&...
April 21, 2026
Market insights predict the global clinical trial imaging industry will increase from USD 2.41 billion in 2024 to USD 5.58 billion by 2034, achieving a CAGR of 8.8%. The market is growing due to the increasing adoption of advanced imaging technologie...
May 04, 2026
Precision Oncology Market (By Product: Therapeutics, Diagnostics; By Cancer Type: Breast Cancer, Cervical Cancer, Colorectal Cancer, Lung Cancer, Blood Cancer, Prostate Cancer, Others; By End-Use: Pharmaceutical & Biotechnology Companies, Hospita...
January 13, 2026
Market insights predict the global hemato-oncology testing industry will increase from USD 4 billion in 2025 to USD 12.88 billion by 2035, achieving a CAGR of 12.4%. In 2023, service offerings led the market with a 58% share. Leukemia remained the to...
April 21, 2026
Oncology Biomarker Market (By Biomarker Type: Genomic Biomarkers, Proteomic Biomarkers, Immunohistochemical Biomarkers, Metabolomic Biomarkers, Other Biomarkers; By Application: Diagnostic Testing, Prognostic Testing, Predictive Testing, Monitoring a...
January 12, 2026
Projections indicate that, surgical microscope industry is projected to rise from USD 1.52 billion in 2025 to USD 4.31 billion by 2035, reflecting a CAGR of 10.97% over the next decade.Investments in healthcare infrastructure, especially in emergin...
March 18, 2026
According to market projections, the oncology devices sector is expected to grow from USD 177.17 billion in 2025 to USD 914.79 billion by 2035, reflecting a CAGR of 17.84%. The increasing prevalence and awareness of cancer and the shift towards perso...
April 21, 2026
The multiple modalities in oncology market is expanding due to increasing tumor heterogeneity as well as growing treatment approaches. North America led the market due to the presence of the advanced healthcare sector....
April 21, 2026
The microfluidics in oncology market is growing due to this system offering more sensitive and precise detection of cancer biomarkers and therapeutic approaches than traditional assays....
April 08, 2026
Oncology Molecular Diagnostics Market ( By Type: Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer Others; By Product: Instruments, Reagents, Others; By Technology: PCR, In-situ...
May 08, 2026
ADC Contract Manufacturing Market (By Service Type: Process Development, Analytical & Quality Control Services, cGMP Manufacturing, Fill-Finish Services, Packaging & Labeling; By Payload Type: Cytotoxic Payloads, DNA Damaging Agents, Topoisom...
April 21, 2026
Based on market forecasts, the global oncology market, projected at USD 225.05 billion in 2024, is expected to reach USD 748.17 billion by 2035, growing at a CAGR of 11.54% over the forecast period.The oncology market is expanding due to rising can...
May 04, 2026
Oncology Companion Diagnostic Market (By Product & Services: Product, Software; By Technology: Polymerase Chain Reaction, Next-generation Sequencing, Immunohistochemistry, In Situ Hybridization (ISH)/Fluorescence In Situ Hybridization, Other Tech...
April 21, 2026
The rising prevalence of cancer and technological advancements are the major growth factors of the market. North America dominated the global market, owing to favorable government initiatives and increasing investments....
May 06, 2026
Oncology Clinical Trial Market (By Phase: Phase I, Phase II, Phase III, Phase IV; By Study Design: Interventional Trials, Observational Trials, Expanded Access Trials; By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Bl...
April 21, 2026
Market insights predict, the investigational new drug CDMO industry is expected to grow from USD 5.66 billion in 2025 to USD 11.10 billion by 2035, driven by a CAGR of 6.97%. The investigational new drug CDMO market is expanding due to increasing dev...
April 21, 2026
Rising advantages of AI and ML in the world are reducing timelines, cost-effective approaches in drug discovery and clinical trials are driving the global market. North America was dominant in the market due to technological advancements by using AI ...
May 06, 2026
Clinical Trial Services Market (By Service Line: Full-Service Clinical Development, Clinical Monitoring & Site Management, Data Management, Biostatistics & Programming, Central Lab & Biomarker Services, Functional Service Provider (FSP)/R...
April 24, 2026
Multispecific Antibodies (By Therapy Type: Bispecific Antibodies, Trispecific Antibodies, Other Multispecific Antibodies; By Application: Oncology, Autoimmune Diseases, Infectious Diseases, Other Therapeutic Areas; By Drug Class: Monoclonal Antibodie...
April 21, 2026
The rapid genomic diagnostics market is rising due to the growing focus on rare disease & genetic disease diagnostics. North America’s dominance is attributed to technological advancements in bioinformatics....
April 21, 2026
Based on market forecasts, the global tele-oncology market, projected at USD 4.74 billion in 2024, is expected to reach USD 20.48 billion by 2034, growing at a CAGR of 15.76% over the forecast period. A sure sign of the adoption of advanced he...
April 21, 2026
Market insights predict the global radionuclide drug conjugates (RDC) industry will increase from USD 3.24 billion in 2024 to USD 8.87 billion by 2034, achieving a CAGR of 10.54%. The global radionuclide drug conjugates (RDC) market is growing stro...
April 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market...
February 17, 2026
Our projections indicate that, the oncology clinical trial monitor market was valued at USD 15.76 billion in 2026 and is projected to reach USD 25.6 billion by 2035, expanding at a CAGR of 5.54% (2026–2035)....
May 04, 2026
Metastatic Breast Cancer Market (By Therapy Type: Chemotherapy, Hormonal Therapy, Targeted Therapy, Immunotherapy; By Cancer Subtype: Hormone Receptor Positive (HR+) / HER2 Negative, HER2 Positive, Triple-Negative Breast Cancer (TNBC); By Route of Ad...
April 21, 2026
Based on market forecasts, the global radiotherapy market, projected at USD 7.88 billion in 2024, is expected to reach USD 15.63 billion by 2034, growing at a CAGR of 7.09% over the forecast period. The market is expanding due to the increasing glo...
April 21, 2026
The U.S. oncology pharmaceutical market is expanding due to increasing cancer awareness as well as growing cancer drug development. ...
February 27, 2026
According to our projections, the AI in oncology for analytical solutions market was valued at USD 1.62 billion in 2025 and is projected to reach USD 2.19 billion in 2026, further expanding to USD 33.87 billion by 2035, registering a robust CAGR of 3...
May 06, 2026
Next-Generation Immune Checkpoint Inhibitors Market (By Target Type: PD-1 Inhibitors, PD-L1 Inhibitors, CTLA-4 Inhibitors, LAG-3 Inhibitors, TIM-3 Inhibitors, TIGIT Inhibitors; By Drug Class: Monoclonal Antibodies, Bispecific Antibodies, Small Molecu...
April 21, 2026
Market insights predict, the oncology biosimilars industry is expected to grow from USD 6.7 billion in 2024 to USD 36.23 billion by 2034, driven by a CAGR of 18.47%. The oncology biosimilars market is witnessing rapid growth, offering similar and c...
January 23, 2026
According to our projections, the acne drugs market is comprehensively analyzed covering global market size valued at USD 10.78 billion in 2026 and projected to reach USD 17.07 billion by 2035, growing at a CAGR of 5.24%...
April 21, 2026
According to market projections, the generic drugs industry is expected to grow from USD 513.02 billion in 2025 to USD 859.84 billion by 2035, driven by a CAGR of 5.3%, driven by the need to reduce healthcare costs. North America leads the market, wh...
April 21, 2026
According to market projections, the pain management drugs sector is expected to grow from USD 84.1 billion in 2024 to USD 126.17 billion by 2034, reflecting a CAGR of 4.14%. The rising prevalence of chronic pain and growing research and development ...
January 22, 2026
According to our forecasts, the antiviral drugs market was valued at USD 65.13 billion in 2026 and is projected to reach approximately USD 89.86 billion by 2035, growing at a CAGR of 3.64% during the forecast period....
February 26, 2026
According to market projections, the nucleic acid drugs sector is expected to grow from USD 57.03 million in 2025 to USD 348.45 million by 2035, reflecting a CAGR of 19.84%. The nucleic acid drugs market is expanding due to advances in delivery techn...
April 21, 2026
Market insights predict, the antitumor ADC drugs industry is expected to grow from USD 7.38 billion in 2025 to USD 24.75 billion by 2035, driven by a CAGR of 12.86%. Rising cancer incidence/unmet needs have driven the growth of the market. North Amer...
February 23, 2026
Based on market forecasts, the global ophthalmology drugs market, projected at USD 45.52 billion in 2025, is expected to reach USD 76.51 billion by 2035, growing at a CAGR of 5.33% over the forecast period. The ophthalmology drugs market is growing...
April 21, 2026
Projections indicate that, hyperkalemia drugs industry is projected to rise from USD 1.42 billion in 2025 to USD 5.20 billion by 2035, reflecting a CAGR of 13.84% over the next decade. The market is growing due to the rising prevalence of chronic kid...
April 21, 2026
According to market projections, the global anticancer drugs market, valued at USD 167.09 billion in 2024, is anticipated to reach USD 401.32 billion by 2034, growing at a CAGR of 9.14% over the next decade. The growing aging population is more susce...
April 21, 2026
Market insights predict the global cancer supportive care drugs industry will increase from USD 21.89 billion in 2024 to USD 27.05 billion by 2034, achieving a CAGR of 2.14%. The increased focus on the prevention and management of the adverse effects...
January 21, 2026
Projections indicate that, the global anti-obesity drugs market will increase from USD 9.11 billion in 2025 to USD 99.74 billion by 2035, experiencing a CAGR of 27.04% over the next 10 years. In 2024, North America led the anti-obesity drugs market, ...
April 02, 2026
Veterinary Ophthalmic Drugs Market (By Drug Class: Anti-infectives, Anti-inflammatory drugs, Anti-glaucoma drugs, Lubricants & artificial Tears, Others; By Animal Type: Companion Animals, Livestock Animals; By Indication: Conjuctivities, Keratiti...
April 21, 2026
Based on market forecasts, the biosynthesis peptide drugs sector will expand from USD 18.31 billion in 2024 to USD 32.88 billion by 2034, experiencing a CAGR of 6.26%. The biosynthesis peptide drugs market is growing, as these drugs offer many advant...
January 19, 2026
According to market projections, the diabetes drugs sector is expected to grow from USD 75.16 billion in 2025 to USD 143.76 billion by 2035, reflecting a CAGR of 6.7%. The diabetes drugs market is growing due to the rising global prevalence of diabet...
April 21, 2026
According to market projections, the hyperlipidemia drugs sector is expected to grow from USD 24.47 billion in 2025 to USD 31.49 billion by 2034, reflecting a CAGR of 2.84%. In 2024, North America led the global hyperlipidemia drugs market, with stat...
April 21, 2026
Based on market forecasts, the global gastrointestinal drugs market, projected at USD 40.21 billion in 2024, is expected to reach USD 55.85 billion by 2034, growing at a CAGR of 3.34% over the forecast period. The gastrointestinal drugs market is gro...
April 21, 2026
According to market projections, the topical drugs CDMO sector is expected to grow from USD 46.32 billion in 2024 to USD 136.71 billion by 2034, reflecting a CAGR of 11.43%. In 2024, Asia Pacific led the topical drugs CDMO market, with Latin America ...
April 21, 2026
According to forecasts, the global respiratory drugs market will grow from USD 17.53 billion in 2024 to USD 30.81 billion by 2034, with an expected CAGR of 5.8%. In 2023, COPD was the most common respiratory disorder, leading the market with a 36% sh...
April 21, 2026
According to market projections, the global insulin drugs and delivery devices market, valued at USD 23.75 billion in 2024, is anticipated to reach USD 49.18 billion by 2034, growing at a CAGR of 7.65% over the next decade. The rising prevalence of d...
April 21, 2026
According to market projections, the global 3D printed drugs market, valued at USD 131.25 million in 2025, is anticipated to reach USD 547.36 million by 2035, growing at a CAGR of 15.35% over the next decade. In 2024, North America led the 3D printed...
January 19, 2026
According to forecasts, the global asthma and COPD drugs market will grow to USD 70.27 billion by 2035, with an expected CAGR of 5.01%. In 2024, King's College London showed that benralizumab can reduce hospitalizations in severe asthma and treat ast...
April 21, 2026
According to market projections, the global antipyretic and analgesic drugs market, valued at USD 47.47 billion in 2024, is anticipated to reach USD 77.99 billion by 2034, growing at a CAGR of 5.09% over the next decade. The rising prevalence of feve...
April 21, 2026
Market insights predict, the epilepsy drugs industry is expected to grow from USD 9.98 billion in 2024 to USD 16.42 billion by 2034, driven by a CAGR of 5.1%. Epilepsy drugs help control seizures by stabilizing brain activity. They work by reducing e...
April 21, 2026
According to forecasts, the global HIV drugs market size will grow from USD 34.75 billion in 2024 to USD 52.95 billion by 2034, with an expected CAGR of 4.3%. In 2023, combination-class drugs led the HIV drugs market with a 60% share, while hospital ...
April 30, 2026
Migraine Drugs Market (By Treatment: Acute, Preventive; By Therapeutic Class: CGRP monoclonal antibodies, CGRP small molecule antagonists, Acetylcholine inhibitors/ neurotoxins, Triptans, Ditans, Ergot alkaloids, NSAIDs, Others; By Route of Administr...
April 21, 2026
Eltrombopag Drugs Market: In October 2024, Jiaheng (Zhuhai Hengqin) Pharmaceutical Technology Company Limited gained approval from China's National Medical Products Administration to market Eltrombopag Olamine tablets. Additionally, in November 2023,...
April 21, 2026
The chemical synthesis peptide drugs market is valued at US$ 2.74 billion in 2025 and is projected to reach US$ 4.82 billion by 2034, growing at a CAGR of 6.54%. Key segments include synthesis methods (chemical, non-chemical), technologies (SPPS, LPP...
April 21, 2026
According to forecasts, the global cardiovascular drugs market will grow from USD 150.02 billion in 2024 to USD 213.36 billion by 2034, with an expected CAGR of 3.65%. The cardiovascular drugs market is expanding due to growing early diagnosis as wel...
April 21, 2026
AI in clinical trials for drugs market is growing due to its use in clinical research to monitor and improve medication adherence. This is particularly through the use of applications, such as facial, digital biomarkers, and vocal expression. AI redu...
April 21, 2026
The anesthesia drugs market size is calculated at $0.669 bn in 2025 is to hit $2.058 bn by 2034. The anesthesia drugs market is growing due to rising surgical procedures, advancements in anesthesia techniques, and increasing demand for outpatient sur...
January 13, 2026
Market insights predict the global rheumatoid arthritis drugs industry will increase from USD 19.55 billion in 2025 to USD 30.65 billion by 2035, achieving a CAGR of 4.6%. Rheumatoid arthritis (RA) drugs help reduce pain, swelling, and joint damage b...
April 13, 2026
Genitourinary Drugs Market (By Indication: Prostate Cancer, Ovarian Cancer, Bladder Cancer, Cervical Cancer, Renal Cancer, Erectile Dysfunction, Urinary Tract Infections, Urinary Incontinence & Overactive Bladder, Sexually Transmitted Diseases, I...
April 21, 2026
According to market projections, the U.S. pain management drugs sector is expected to grow from USD 31.84 billion in 2024 to USD 44.92 billion by 2034, reflecting a CAGR of 3.64%. The U.S. pain management drugs market is growing due to rising cases o...
April 21, 2026
Projections indicate that, anti-inflammatory drugs industry is projected to rise from USD 122.32 billion in 2024 to USD 274.79 billion by 2034, reflecting a CAGR of 8.43% over the next decade. In 2024, North America led the anti-inflammatory drugs ma...
April 21, 2026
According to forecasts, the global antipsychotic drugs market will grow from USD 19.45 billion in 2024 to USD 41.21 billion by 2034, with an expected CAGR of 7.8%. Antipsychotic drugs help manage symptoms of mental health conditions like schizophreni...
April 21, 2026
According to market projections, the global liver cancer drugs market, valued at USD 3.05 billion in 2024, is anticipated to reach USD 11.5 billion by 2034, growing at a CAGR of 14.2% over the next decade. Liver cancer drugs are medicines used to tre...
April 09, 2026
Drugs Market ( By Product Type: Prescription Drugs Over-the-Counter (OTC) Drugs; By Therapeutic Area: Oncology, Cardiovascular, Central Nervous System, Respiratory, Infectious Diseases, Gastrointestinal, Diabetes, Autoimmune Disorders, Dermatology, O...
February 03, 2026
Based on market forecasts, the global Non-steroidal anti-inflammatory drugs market, projected at USD 23.16 billion in 2025, is expected to reach USD 37.73 billion by 2035, growing at a CAGR of 5% over the forecast period. Arthritis dominated the NSAI...
April 21, 2026
The market is growing due to its ability to accelerate drug discovery and optimize personalized treatment strategies. This leads to faster development timelines, reduced costs, and improved patient outcomes....
April 27, 2026
Over the Counter (OCT) Drugs Market (By Product Type: Cough & Cold Products, Analgesics, Vitamin & Dietary Supplements, Gastrointestinal Products, Sleep Aids, Otic Products, Wart Removers, Mouth Care Products, Ophthalmic Products, Botanicals,...
April 21, 2026
The organ transplant immunosuppressant drugs market size is calculated at $5.81 bn in 2025 is to hit $8.82 bn by 2034. In 2024, Eledon Pharmaceuticals showed positive trial results for tegoprubart in islet transplant recipients with type 1 diabetes. ...
April 21, 2026
Market insights predict the global inhalation and nasal spray generic drugs industry will increase from USD 25.18 billion in 2025 to USD 59.35 billion by 2035, achieving a CAGR of 8.99%. The inhalation and nasal spray generic drugs market is expandin...
April 21, 2026
According to market projections, the GLP-1 drugs sector is expected to grow from USD 52.95 billion in 2025 to USD 132.79 billion by 2035, reflecting a CAGR of 9.63%. The GLP-1 drugs market is expanding due to increasing incidences of type 2 diabetes ...
April 21, 2026
Based on market forecasts, the targeted drugs for allergic diseases sector will expand from USD 13.96 billion in 2024 to USD 30.22 billion by 2034, experiencing a CAGR of 8.06%. The targeted drugs for allergic diseases market is growing due to rising...
April 30, 2026
Anti-Hypertensive Drugs Market (By Product Type: Tablets & Capsules, Fixed-Dose Combination (FDC) Tablets, Injectable, Vials/ampoules, Pre-filled syringes, Liquids & Suspensions, Transdermal Patches, Extended-release patch systems, Othe...
April 21, 2026
Market insights predict the global pediatric drugs industry will increase from USD 144.88 billion in 2024 to USD 458.09 billion by 2034, achieving a CAGR of 12.2%. Pediatric drugs are medicines specially designed for children to treat illnesses, mana...
April 21, 2026
According to market projections, the global sinusitis drugs market, valued at USD 2.33 billion in 2025, is anticipated to reach USD 4.16 billion by 2035, growing at a CAGR of 5.96% over the next decade. The growing research activities and increasing ...
April 21, 2026
According to market projections, the antimalarial drugs sector is expected to grow from USD 1.07 billion in 2024 to USD 1.67 billion by 2034, reflecting a CAGR of 4.57%. Establishing awareness and government programs are propelling the global market ...
April 21, 2026
According to market projections, the global pulmonary arterial hypertension drugs market, valued at USD 8.04 billion in 2024, is anticipated to reach USD 12.38 billion by 2034, growing at a CAGR of 4.44% over the next decade. The market is growing du...
February 20, 2026
Based on our estimations, the intravenous iron drugs market was valued at USD 3.65 billion in 2025 and reached USD 3.98 billion in 2026, and is projected to grow to USD 8.74 billion by 2035, expanding at a CAGR of 9.14% (2026–2035)....
April 21, 2026
According to forecasts, the global age-related macular degeneration (AMD) drugs market will grow from USD 10.57 billion in 2024 to USD 29.04 billion by 2034, with an expected CAGR of 10.66%. Rising patient demand for a better quality of life is estim...
April 21, 2026
According to market projections, the pelvic inflammatory disease treatment sector is expected to grow from USD 3.52 billion in 2024 to USD 5.09 billion by 2034, reflecting a CAGR of 3.75%. In 2024, North America led the global pelvic inflammatory dis...
April 21, 2026
According to market estimations the global leuprorelin drugs market, valued at US$ 2.60 billion in 2023, is projected to reach US$ 4.78 billion by 2034, driven by rising cancer cases and gender-affirming surgeries. North America leads the market, w...
February 19, 2026
According to our forecasts, the invasive fungal disease (IFD) drugs market was valued at USD 3.11 billion in 2025 and is projected to grow from USD 3.29 billion in 2026 to USD 5.34 billion by 2035, expanding at a CAGR of 5.55% during 2026–2035....
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com